Not Medicare Enrolled

Dr. Dale Halter, M.D.

Rheumatology · Houston, TX
Speaking/Promotional
902 FROSTWOOD DR, Houston, TX 77024
7132661946
In practice since 2005 (20 years)
NPI: 1083617310 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Halter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Halter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Halter

Dr. Dale Halter is a rheumatology specialist in Houston, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Halter received a total of $30,039 from 22 pharmaceutical and/or device companies across 314 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Halter is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $30,039 industry payments

Industry Payment Transparency

Open Payments through 2020 ↗
$30,039
Total received (2018-2020)
Avg $10,013/year across 3 years
Top 14% in TX for rheumatology
22
Companies
314
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13,435 (44.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$11,413 (38.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,191 (17.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2020
$10,000
2019
$16,210
2018
$3,829

Payments by company (2020)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$10,836
United Rheumatology
$10,000
Horizon Therapeutics plc
$2,837
PFIZER INC.
$1,734
Amgen Inc.
$1,133
UCB, Inc.
$587
GENZYME CORPORATION
$465
Lilly USA, LLC
$453
E.R. Squibb & Sons, L.L.C.
$416
AbbVie, Inc.
$398
Radius Health, Inc.
$242
Janssen Biotech, Inc.
$189
Celgene Corporation
$139
Horizon Pharma plc
$132
GlaxoSmithKline, LLC.
$125
Genentech USA, Inc.
$121
SANOFI-AVENTIS U.S. LLC
$103
MEDEXUS PHARMA, INC.
$58
Mallinckrodt Enterprises LLC
$23
MEDAC PHARMA, INC.
$19
Mission Pharmacal Company
$16
Flexion Therapeutics, Inc.
$14
Top 3 companies account for 78.8% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Aquoral · BENLYSTA · COSENTYX · Cimzia · EVENITY · Enbrel · FORTEO · Humira · ILARIS · KEVZARA · KRYSTEXXA · ORENCIA · Otezla · PENNSAID · Prolia · RAYOS · RHEUMATOID ARTHRITIS DISEASE · Rasuvo · Rinvoq · Rituxan · SIMPONI · SIMPONI ARIA · TALTZ · Tymlos · VIMOVO · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (45%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a rheumatology specialist in Houston?
Compare rheumatologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
79
Per 100K population
1.7
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2020
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Halter is a rheumatology specialist, with speaking/promotional industry engagement in the top 14% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Halter receive payments from pharmaceutical companies?
Yes. Dr. Halter received a total of $30,039 from 22 companies across 314 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Halter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Rheumatologists in Houston
Browse rheumatologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
United Rheumatology Payments to Doctors
See all physicians who received payments from United Rheumatology.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →